• The scholar had acquired a combined routine of Sinovac and AstraZeneca COVID-19 vaccines
  • She suffered a mind hemorrhage after taking medicines to deal with blood clots
  • Her household has acquired monetary help from the federal government

A 20-year-old scholar whose leg was amputated after getting a COVID-19 vaccine has died of blood clots within the mind. 

Ketsiree Kongkaew, who studied at Phangnga Neighborhood Faculty in Thailand, died of a hemorrhagic stroke after mind surgical procedure. The scholar had remained unconscious following the surgical procedure and wanted a ventilator to breathe. She was pronounced lifeless Monday.

The younger girl, who had been admitted to the Songklanagarind Hospital, had beforehand gotten her left leg amputated after she developed blood clots following her second dose of COVID-19 vaccine, in line with The Bangkok Put up. 

Kongkaew had acquired two completely different vaccine manufacturers for her first and second pictures. Her first dose was a COVID-19 vaccine developed by China’s SinoVac and the second was from Oxford-AstraZeneca.

The mind hemorrhage that docs tried to deal with Monday was the results of thrombolytic medication she was taking to deal with blood clots, Anupong Thammarong, Kongkaew’s classmate, informed the publication. 

Kongkaew first felt unwell after receiving her second shot of the COVID-19 vaccine on Aug. 13. The scholar complained of a fever and chest pains on Aug 16. On the time, a physician on the Phangnga Hospital identified her with a bladder an infection. 

She was rushed again to the hospital after complaining about extreme ache in her left leg. An X-ray later revealed she had blood clots that required pressing surgical procedure. Due to her situation, Kongkaew was transferred to a number of hospitals earlier than docs on the Songklanagrind Hospital determined to amputate her leg. 

Her household has acquired 400,000 Thai Baht in household monetary help from the nation’s Nationwide Well being Safety Workplace.

The AstraZeneca COVID-19 vaccine has beforehand been linked to uncommon blood clots known as thrombosis together with thrombocytopenia. Whereas uncommon, researchers have seen greater charges of the aspect impact occurring in folks aged 50 to 59, in line with the Australian Division of Well being.

It’s nonetheless unclear how the AstraZeneca COVID-19 vaccine pictures trigger uncommon blood clots in some recipients. Nonetheless, scientists in Germany advised that the two-step mechanism wanted by the vaccine to activate could also be one of many causes, in line with WebMD.

The trial will check the efficacy of mixing an ‘inactivated’ vaccine made by China’s Sinovac with a DNA-based one Photograph: AFP / Lillian SUWANRUMPHA